Isabelle Madelaine-Chambrin Selected Research

Isabelle Madelaine-Chambrin Research Topics

3	Melanoma (Melanoma, Malignant) 01/2018 - 10/2017
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2018 - 11/2017
2	Infections 10/2009 - 08/2007
1	Neoplasms (Cancer) 05/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2018
1	Insulin Resistance 01/2018
1	Pain (Aches) 10/2017
1	Muscular Diseases (Myopathy) 10/2017
1	Fatigue 10/2017
1	Dropped Head Syndrome 10/2017
1	Muscle Hypotonia (Hypotonia) 10/2017
1	HIV Infections (HIV Infection) 09/2011
1	Dermatofibrosarcoma 06/2010
1	Multi-centric Castleman's Disease 08/2007
1	Breast Neoplasms (Breast Cancer) 03/2007
1	Lymphoma (Lymphomas) 03/2005
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2003
1	Blast Crisis (Blast Phase) 11/2003

3	Immune Checkpoint InhibitorsIBA 05/2019 - 10/2017
2	Raltegravir Potassium FDA Link 09/2011 - 10/2009
2	RNA (Ribonucleic Acid)IBA 09/2011 - 10/2009
2	Enfuvirtide (Fuzeon)FDA Link 09/2011 - 10/2009
2	Imatinib Mesylate (Gleevec)FDA Link 06/2010 - 11/2003
1	AntibodiesIBA 01/2018
1	Blood Glucose (Blood Sugar)IBA 01/2018
1	C-Reactive ProteinIBA 01/2018
1	Interleukin-2 (IL2)IBA 01/2018
1	NivolumabIBA 11/2017
1	VemurafenibIBA 10/2017
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2017
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2017
1	cobimetinibIBA 10/2017
1	Antiviral Agents (Antivirals)IBA 09/2011
1	Rituximab (Mabthera)FDA Link 08/2007
1	Gemcitabine FDA Link 03/2007
1	AnthracyclinesIBA 03/2007
1	taxaneIBA 03/2007
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2007
1	Tyrosine Kinase InhibitorsIBA 11/2003
1	Orosomucoid (Seromucoid)IBA 11/2003